GENE ONLINE|News &
Opinion
Blog

2019-11-05| China

2019 CSCO China, with highlights on proteomics-driven precision medicine, oncology treatment and quality control, and breakthroughs in drug developments

by GeneOnline
Share To
The 22nd annual installment of the Chinese Society of Clinical Oncology (CSCO) meeting, took place at the Xiamen International Conference Center on September 19, for 4 days. The theme of the 22nd conference was “Precision & Intelligence: Hope to conquer cancer”. The conference had four aims: (1) Encourage the exchange of new knowledge and technology in clinical oncology; (2) Promote scientific exchange between China and other countries; (3) Support academic research; (4) Support innovation in the industry. The conference attracted approximately 30,000 participants, more than 600 speakers and paper presenters from China and abroad, and 275 manufacturers from China. Geneonline attended the CSCO meeting, and reported the highlights of this conference.

GO Prime with only $1.49 now

LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top